Author

S. V. Ranganathan

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Biophysics· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

A. Yildirim· 1 shared E. S. Ozdemir· 1 shared F. Shen· 1 shared H. H. Le· 1 shared J. Sheng· 1 shared P. Haruehanroengra· 1 shared S. Mao· 1 shared T. Begley· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiophysics

A. Yildirim

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

In silico screening and testing of FDA approved small molecules to block SARS-CoV-2 entry to the host cell by inhibiting Spike protein cleavage

E. S. Ozdemir, H. H. Le, A. Yildirim, S. V. Ranganathan

This study uses a computational pipeline to identify FDA-approved drugs that inhibit SARS-CoV-2 Spike protein cleavage, reducing protease activity and potentially preventing viral entry.

bioRxiv · Mar 7, 2022Biophysics

Base Pairing and Functional Insights into N3-methylcytidine (m3C) in RNA

S. Mao, P. Haruehanroengra, S. V. Ranganathan, F. Shen, T. Begley, J. Sheng

This study investigates the effects of N3-methylcytidine (m3C) modification on RNA base pairing and reverse transcription, showing its impact on stability, discrimination, and mutation induction.

bioRxiv · Aug 27, 2020Biochemistry